To Study The Effect Of Loha Rasayana In Comparison To Vyoshadi Saktu On Atherogenic Index of Plasma (AIP) In Patients Of Metabolic Syndrome - An Open Labelled Randomized Comparative Clinical Trial.

Efficacy Of Loha Rasayana and Vyoshadi Saktu On Atherogenic Index Of Plasma (AIP) In Patients Of Metabolic Syndrome - An Open Labelled Randomized Comparative Clinical Trial. - METS

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063165

Enrollment

Registered

2024-02-26

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E888- Other specified metabolic disorders

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the Diagnostic criteria of Metabolic Syndrome. Patients fit for Virechana Karma.

Exclusion criteria

Exclusion criteria: Age group below 30 years and above 60 years. Patients not fulfilling the Diagnostic criteria of Metabolic Syndrome

Design outcomes

Primary

Measure	Time frame
•Changes in the Atherogenic Index of Plasma Timepoint: 3 timepoints 1. Baseline 2. 4 weeks 3. 8 weeks	—

Secondary

Measure	Time frame
Changes in the Medoroga Lakshana, Anthropometric measurements, Fasting Blood Glucose levels & Blood Pressure. Changes in the number of components of the metabolic syndrome; Changes in single indicators (waist circumference, blood pressure, TG, HDL-C) in metabolic syndrome; Ankle brachial index; Glycated hemoglobin (HbA1c); C-reactive protein; Urinary microalbumin to creatinine ratio (ACR). Timepoint: 3 timepoints 1. Baseline 2. 4 weeks 3. 8 weeks	—

Measure

Time frame

Changes in the Medoroga Lakshana, Anthropometric measurements, Fasting Blood Glucose levels & Blood Pressure. Changes in the number of components of the metabolic syndrome; Changes in single indicators (waist circumference, blood pressure, TG, HDL-C) in metabolic syndrome; Ankle brachial index; Glycated hemoglobin (HbA1c); C-reactive protein; Urinary microalbumin to creatinine ratio (ACR). Timepoint: 3 timepoints 1. Baseline 2. 4 weeks 3. 8 weeks

—

Countries

India

Contacts

Public ContactDr Chandrika Kuraakula

All India Institute of Ayurveda, New Delhi

jonahdr@gmail.com9448262298

Outcome results